Quantitative interactions between cryptdin-4 amino terminal variants and membranes

Area of Science:

• Microbiology
• Immunology
• Biochemistry

Background:

• Paneth cells in the small intestine secrete alpha-defensins.
• Cryptdin-4 (Crp4) is identified as a highly potent mouse alpha-defensin in vitro.
• Alpha-defensins play a critical role in innate immunity and host defense within the gastrointestinal tract.

Purpose of the Study:

• To investigate the bactericidal activity of purified recombinant Crp4 and its variants.
• To elucidate the structure-activity relationship of Crp4, focusing on N-terminal modifications.
• To determine the mechanism by which Crp4 exerts its antimicrobial effects on Escherichia coli.

Main Methods:

• Bactericidal assays were performed using purified recombinant Crp4 and its modified variants.
• Membrane permeabilization of live Escherichia coli was assessed.
• Equilibrium binding studies with E. coli membrane phospholipid bilayers and vesicles were conducted.
• Fluorophore leakage from phospholipid vesicles was measured to evaluate membrane disruption.

Main Results:

• Crp4 and its variants, including (Gly1Arg)-Crp4, demonstrated significant bactericidal activity.
• Bactericidal activity correlated with the ability to permeabilize E. coli membranes.
• Crp4 exhibited equilibrium binding to phospholipid bilayers and vesicles, inducing fluorophore leakage.
• The N-terminus of Crp4 was found to modestly influence its bactericidal activity by affecting membrane interactions.

Conclusions:

• Cryptdin-4 is a potent antimicrobial peptide with significant bactericidal effects.
• The mechanism of action involves direct interaction with and permeabilization of bacterial membranes.
• N-terminal modifications can modulate the antimicrobial potency of Crp4, highlighting its importance in peptide-membrane interactions.